S'abonner

Monitoring Quality of Life Among Prostate Cancer Survivors: The Feasibility of Automated Telephone Assessment - 30/10/12

Doi : 10.1016/j.urology.2012.07.038 
Ted A. Skolarus a, b, , Margaret Holmes-Rovner c, Sarah T. Hawley a, d, Rodney L. Dunn b, Kathryn L.C. Barr e, Nancy R. Willard e, John T. Wei a, b, John D. Piette a, d, Lawrence C. An a, d, e
a Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI 
b Dow Division of Health Services Research, Department of Urology, University of Michigan, Ann Arbor, MI 
c Health Services Research, Center for Ethics and Humanities, Michigan State University College of Human Medicine, East Lansing, MI 
d Department of Internal Medicine, University of Michigan, Ann Arbor, MI 
e Center for Health Communications Research, University of Michigan, Ann Arbor, MI 

Reprint requests: Ted A. Skolarus, M.D., M.P.H. Department of Urology, University of Michigan, VA Center for Clinical Management Research, VA Ann Arbor Healthcare System, 1500 E. Medical Center Drive, 3875 Taubman Center, SPC 5330, Ann Arbor, MI 48019

Résumé

Objective

To examine the feasibility of using automated interactive voice response calls to assess prostate cancer survivor quality of life (QOL). In light of an increasing focus on patient-centered outcomes, innovative and efficient approaches to monitor QOL among prostate cancer survivors are increasingly valuable.

Methods

Forty prostate cancer survivors less than 1 year post-treatment were enrolled at a university-based cancer center clinic from July through August 2011. We adapted the Expanded Prostate Cancer Index Composite (EPIC) survey, a prostate cancer-specific QOL instrument, for use via personal telephone with interactive voice response. We compared written vs interactive voice response EPIC scores across urinary, sexual, bowel, and vitality domains.

Results

The median age of respondents was 63 years (range, 41-76 years) and the majority had undergone surgery (97.5%). The entire interactive voice response call was completed by 35 participants (87.5%). Over half of all interactive voice response calls were answered after 2 attempts with a median length of 11.3 minutes. On average, interactive voice response EPIC scores were slightly lower than written scores (−2.1 bowel, P = .05; −4.6 urinary incontinence, P < .01). Test-retest reliability was very high for urinary incontinence (r = .97) and sexual function domains (r = .96). Although mean scores were similar for other domains, their distributions had significant ceiling effects limiting our reliability measure interpretation.

Conclusion

Automated interactive voice response calls are a feasible strategy for assessing prostate cancer survivor QOL. Interactive voice response could provide a low cost, sustainable, and systematic approach to measuring patient-centered outcomes, conducting comparative effectiveness research, and monitoring the quality of prostate cancer care.

Le texte complet de cet article est disponible en PDF.

Plan


 Financial Disclosure: The authors declare that they have no relevant financial interests.
 Funding Support: This study was supported with funding from the Blue Cross Blue Shield of Michigan Foundation and the Prostate Cancer Income Tax Check-Off Fund, administered by the Michigan Department of Community Health. Dr. Skolarus was supported by a National Institutes of Health T32 training grant (NIH 2 T32 DK007782-06). Dr. John Piette is a VA Senior Research Career Scientist.
 The contents of this article do not necessarily represent the official views of the Blue Cross Blue Shield of Michigan Foundation or the Michigan Department of Community Health.


© 2012  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 80 - N° 5

P. 1021-1026 - novembre 2012 Retour au numéro
Article précédent Article précédent
  • Certificate of Need Regulations and the Diffusion of Intensity-modulated Radiotherapy
  • Bruce L. Jacobs, Yun Zhang, Ted A. Skolarus, John T. Wei, James E. Montie, Florian R. Schroeck, Brent K. Hollenbeck
| Article suivant Article suivant
  • Socioeconomic and Clinical Factors Influence the Interval Between Positive Prostate Biopsy and Radical Prostatectomy
  • Max Pitman, Ruslan Korets, Max Kates, Gregory W. Hruby, James M. McKiernan

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.